Perioperative Assessment of Right Ventricular Function and Venous Return in Patients With Epithelial Ovarian Cancer Undergoing Cytoreductive Surgery (Gyn Right) - Pilot Study
NCT02291276 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2017-07-19
Summary
In this prospective, observational study the investigators assess the perioperative course of right ventricular function in combination with the venous return in patients undergoing major non-cardiac surgery. The study aims to investigate if patients undergoing major non-cardiac surgery develop an impairment of right ventricular function and/or venous return. Furthermore, the study evaluates if an impairment of right ventricular function and/or venous return is associated to left ventricular function, arterial side of the circulation and to postoperative clinical outcome.
Conditions
- Right Ventricular Function and Venous Return
Sponsors & Collaborators
-
Charite University, Berlin, Germany
lead OTHER
Principal Investigators
-
Claudia Spies, MD, Prof. · Charite University, Berlin, Germany
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-11-30
- Primary Completion
- 2016-11-30
- Completion
- 2017-04-30
Countries
- Germany
Study Locations
More Related Trials
-
Cytoreductive Surgery and HIPEC in First or Secondary Platinum-resistant Recurrent Ovarian Epithelial Cancer
NCT03220932 ·Status: UNKNOWN ·Phase: PHASE3
-
Evaluation of the Predictive Value of Blood Levels of Angiopoietin 1 and Endothelial Internal Tunica Cell Kinase 2 in Patients With Ovarian Cancer Treated With Chemotherapy Associated to Bevacizumab
NCT04770376 ·Status: UNKNOWN
-
Prehabilitation for Stage IIIC-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients
NCT05047926 ·Status: COMPLETED ·Phase: NA
-
The Preoperative Predictors of Optimal Cytoreductive Surgery in Women With Advanced Ovarian Cancer
NCT02856841 ·Status: COMPLETED
-
Evaluation of Optimal Treatment Duration of Bevacizumab Combination With Standard Chemotherapy in Patients With Ovarian Cancer
NCT01462890 ·Status: COMPLETED ·Phase: PHASE3
-
Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy
NCT01080521 ·Status: COMPLETED
-
VATS IN PATIENTS WITH ADVANCED OVARIAN MALIGNANCIES
NCT05840029 ·Status: UNKNOWN
-
Phase 3 Trial Evaluating Hyperthermic Intraperitoneal Chemotherapy in Upfront Treatment of Stage IIIC Epithelial Ovarian Cancer
NCT01628380 ·Status: UNKNOWN ·Phase: PHASE3
-
Prehabilitation Care for Women With Advanced Ovarian Cancer Receiving Neoadjuvant Chemotherapy
NCT04204811 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Primary Cyto-reductive Surgery Vs Neo-adjuvant Chemotherapy (NAC) in Epithelial Ovarian Cancer
NCT04257786 ·Status: UNKNOWN ·Phase: NA
-
Venous Thromboembolic Complications in Ovarian Cancer
NCT02480790 ·Status: UNKNOWN
-
Efficacy of HIPEC in the Treatment of Advanced-Stage Epithelial Ovarian Cancer After Cytoreductive Surgery
NCT03373058 ·Status: UNKNOWN ·Phase: PHASE3
-
Role of Surgery in Advanced Ovarian Cancer
NCT03980028 ·Status: COMPLETED
-
Secondary Interval Cytoreductive Surgery in Platinum-sensitive Recurrent Epithelial Ovarian Cancer
NCT06292286 ·Status: RECRUITING ·Phase: NA
-
Removal of the Ovaries/Fallopian Tubes and CA-125 Screening to Reduce the Risk of Ovarian Cancer in Women at Increased Genetic Risk
NCT00043472 ·Status: COMPLETED
-
Surgery and Chemotherapy With or Without Chemotherapy After Surgery in Treating Patients With Ovarian, Fallopian Tube, Uterine, or Peritoneal Cancer
NCT01970722 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Neoadjuvant Therapy for Ovarian Cancer
NCT01146795 ·Status: COMPLETED ·Phase: PHASE2
-
Improving Quality of Care for Patients With Recurrent Ovarian Cancer
NCT02809339 ·Status: UNKNOWN
-
Study of Acute Normovolemic Hemodilution (ANH) in People With Ovarian Cancer Who Are Having Cytoreductive Surgery
NCT06290193 ·Status: RECRUITING ·Phase: PHASE2
-
Interval Cytoreductive Surgery With or Without HIPEC for Ovarian Cancer (FOCUS / KOV-HIPEC-04)
NCT05827523 ·Status: RECRUITING ·Phase: PHASE3
-
Development for the Peritoneal Carcinomatosis Index (PCI) in Ovarian Cancer
NCT01538498 ·Status: COMPLETED
-
The SOCQER-2 Study Surgery in Ovarian Cancer - Quality of Life Evaluation Research
NCT02569983 ·Status: COMPLETED
-
Blood Collection From People With Ovarian Cancer
NCT02063464 ·Status: COMPLETED
-
Neoadjuvant Chemotherapy IV Carboplatin With Weekly Paclitaxel \Bevacizumab for Primary Ovarian
NCT01219777 ·Status: COMPLETED ·Phase: PHASE1
-
EC17 for Intraoperative Imaging in Occult Ovarian Cancer
NCT02000778 ·Status: COMPLETED ·Phase: PHASE1